1
RG2 d 0 5 12 40 Ad-Flt3L/TK Rapamycin (150µg/kg/day) GCV a b Supplementary figure 5:Low dose Rapamycin does not enhance Ad-Flt3L + Ad-TK/GCV immunotherapy

RG2

Embed Size (px)

DESCRIPTION

RG2. Ad-Flt3L/TK. Rapamycin (150 µg/kg/day). 40. GCV. d 0. 5. 12. Supplementary figure 5: Low dose Rapamycin does not enhance Ad-Flt3L + Ad-TK/GCV immunotherapy. a. b. - PowerPoint PPT Presentation

Citation preview

Page 1: RG2

RG2

d 0 5 12

40

Ad-Flt3L/TK

Rapamycin (150µg/kg/day)

GCV

a

b

Supplementary figure 5:Low dose Rapamycin does not enhance Ad-Flt3L + Ad-TK/GCV immunotherapy